KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sabra Health Care REIT (SBRA) Cash from Investing Activities (2016 - 2025)

Sabra Health Care REIT (SBRA) has 15 years of Cash from Investing Activities data on record, last reported at -$116.5 million in Q4 2025.

  • For Q4 2025, Cash from Investing Activities fell 727.94% year-over-year to -$116.5 million; the TTM value through Dec 2025 reached -$378.0 million, down 246.75%, while the annual FY2025 figure was -$378.0 million, 246.75% down from the prior year.
  • Cash from Investing Activities reached -$116.5 million in Q4 2025 per SBRA's latest filing, up from -$199.8 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $113.2 million in Q1 2023 and bottomed at -$258.8 million in Q4 2021.
  • Average Cash from Investing Activities over 5 years is -$46.8 million, with a median of -$39.5 million recorded in 2021.
  • Peak YoY movement for Cash from Investing Activities: crashed 35968.99% in 2022, then soared 403.89% in 2023.
  • A 5-year view of Cash from Investing Activities shows it stood at -$258.8 million in 2021, then surged by 87.96% to -$31.2 million in 2022, then tumbled by 98.26% to -$61.8 million in 2023, then soared by 130.04% to $18.6 million in 2024, then tumbled by 727.94% to -$116.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Cash from Investing Activities were -$116.5 million in Q4 2025, -$199.8 million in Q3 2025, and -$45.1 million in Q2 2025.